XML 59 R48.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation (Tables)
6 Months Ended
Oct. 28, 2018
Summary of Assumptions Used to Determine Fair Value of Performance Based Restricted Stock Units

The following table provides assumptions used to determine the fair market value of the market-based shareholder return component using the Monte Carlo simulation model on the date of grants noted above:

 

     Fiscal 2019     Fiscal 2018  

Closing price of our common stock

   $ 24.35     $ 32.50  

Expected volatility of our common stock

     33.5     31.0

Expected volatility of peer companies

     16.0     16.5

Risk-free interest rate

     2.74     1.56

Dividend yield

     1.35     1.66

Correlation coefficient of peer companies

     0.47       0.46  
Summary of Vested Performance Based Restricted Stock Units

The following table summarizes information related to our performance based restricted stock units that vested during the six-month periods ending October 28, 2018 and October 29, 2017:

 

Fiscal Year

   Common Stock
Shares Vested
     (3)
Weighted Average
Fair Value
     Price
Per Share
 

Fiscal 2019 (1)

     107,553      $ 3,466      $ 32.23  (4) 

Fiscal 2019 (2)

     10,364      $ 320      $ 30.90  (5) 

Fiscal 2018 (1)

     102,845      $ 1,820      $ 17.70  (4) 

Fiscal 2018 (2)

     16,000      $ 520      $ 32.50  (5) 

 

(1)

NEOs and key employees.

(2)

Non-employee

(3)

Dollar amounts are in thousands.

(4)

Price per share represents closing price of our common stock on the date of grant.

(5)

The respective grant vested during the first quarter of fiscal 2019 or 2018, respectively. Accordingly, the price per share represents the closing price of our common stock on the date the award vested.

Non-employee [Member]  
Summary of Grants of Performance Based Restricted Stock Units

The following table summarizes information related to our grants of performance-based restricted stock units associated with a non-employee that are currently unvested:

 

Date of Grant

   (1)
Restricted Stock
Units Awarded
     Price Per
Share
    Vesting
Period
 

July 14, 2016

     11,549      $ 22.31  (2)      3 years  

 

(1)

Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements.

(2)

The respective grant was unvested at the end of our reporting period. Accordingly, the price per share represents the closing price of our common stock on October 28, 2018, the end of our reporting period.

NEOs and Key Employees [Member]  
Summary of Grants of Performance Based Restricted Stock Units

The following table summarizes information related to our grants of performance based restricted stock units associated with NEOs and key employees that are currently unvested:

 

Date of Grant

   (3)
Restricted Stock
Units Awarded
     Price Per
Share
    Vesting
Period
 

August 2, 2018 (1)

     86,599      $ 18.51  (4)      3 years  

August 2, 2018 (2)

     47,800      $ 24.35  (6)      3 years  

July 13, 2017 (1)

     78,195      $ 31.85  (5)      3 years  

July 13, 2017 (2)

     44,000      $ 32.50  (6)      3 years  

July 14, 2016 (1) (2)

     107,880      $ 28.00  (6)      3 years  

 

(1)

Performance-based restricted stock units awarded to NEOs.

(2)

Performance-based restricted stock units awarded to key employees.

(3)

Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements.

(4)

Price per share represents the fair market value per share ($0.76 per $1 or a reduction of $5.84 to the closing price of the our common stock) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($24.35) for the performance-based components of the performance-based restricted stock units granted to our NEOs on August 2, 2018.

(5)

Price per share represents the fair market value per share ($0.98 per $1 or a reduction of $0.65 to the closing price of the our common stock) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($32.50) for the performance-based components of the performance-based restricted stock units granted to our NEOs on July 13, 2017.

(6)

Price per share represents the closing price of our common stock on the date of grant.